SIGA wins up to $15M Canadian defence contract to supply TPOXX
SIGA Technologies won a contract worth up to $15 million from Canada for TPOXX purchases running to March 2031, Reuters and Seeking Alpha reported.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
SIGA Technologies said Public Services and Procurement Canada (PSPC) has awarded it a new contract to buy oral TPOXX (tecovirimat) for the Canadian Department of National Defence (CDND) under its Strategic Medical Countermeasures Program. The deal allows purchases of up to about $15 million through March 31, 2031.
About $9 million represents firm commitments over the first three years, while roughly $6 million depends on options that CDND may exercise. It is the second TPOXX contract PSPC has awarded on behalf of CDND. The earlier one, worth up to about $14 million, was signed in April 2020 and its final delivery was made in 2025. Reuters and Seeking Alpha reported the details.
why it matters
For SIGA shares this is a small contract, so its effect on the stock is likely limited. The news shows that government buyers keep purchasing smallpox antivirals, and a repeat order from Canada points to continued demand for the product in that market.
tags
instruments
sources
- Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx® — Reuters, 28 October 2026 at 11:33 UTC
- SIGA secures $15M contract from Canadian Department of National Defence — Seeking Alpha, 28 October 2026 at 11:39 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗